Granules India FY26 Revenue Hits ₹53,656Mn, Up 20%

Granules India reported FY26 revenue of ₹53,656Mn, a 20% YoY growth, achieving a record gross margin of 65.0%.
EBITDA grew 25% YoY to ₹11,851Mn with margin expansion of 100 bps, while PAT increased 19% YoY to ₹5,950Mn.
The company significantly shifted its portfolio with Complex Generics now comprising 43% of Finished Dosages, up from 31% last year.
Peptide CDMO business achieved positive EBITDA in Q4FY26, contributing ₹1,593Mn for the full year as a new growth vertical.